Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Methylprednisolone is not specifically approved by the FDA or EMA as a disease-modifying anti-rheumatic drug (DMARD) for rheumatoid arthritis (RA), but it is widely used as an adjunct or symptomatic therapy for RA due to its anti-inflammatory and immunosuppressive effects. Both agencies recognize systemic corticosteroids like methylprednisolone for managing acute exacerbations or as bridging therapy in RA, but formal approvals are more often granted to DMARDs and targeted therapies
Moura et al. 2018 M…